MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, CVAT had $1K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$1K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-12-31
2025-09-30
2025-06-30
Net income (loss)
-476 -258 -113
Depreciation
--0
Fair value of common stock issued for services
244 -195
Fair value of common stock issued for services
--6
Fair value of warrants granted for services
0 --
Gain on patent assignment
0 --880
Accounts receivable
-5 -5 10
Prepaid expenses
0 -13 11
Operating lease right of use asset
0 0 42
Accounts payable and accrued expenses
45 21 0
Accrued payroll and payroll taxes related parties
-0 11
Customer advances
--0
Operating lease liability
0 0 -46
Net cash used in operating activities
-182 -219 -806
Proceeds from patent assignment
0 -880
Net cash provided by investing activities
0 -880
Proceeds from convertible note payable
10 --
Proceeds from common stock units
173 --
Repayment of note payable
0 0 4
Net cash provided by (used in) financing activities
183 0 -4
Net (decrease) increase in cash and cash equivalents
1 -219 70
Cash and cash equivalents at beginning of period
30 249 179
Cash and cash equivalents at end of period
31 30 249
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Cavitation Technologies, Inc. (CVAT)

Cavitation Technologies, Inc. (CVAT)